ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
84 404,93
0,52%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Arcutis Biotherapeutics Inc (ARQT) Cours

Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc (ARQT)

NASDAQ
14,62
-0,19
(-1,28%)
Fermé 15 Mars 9:00PM
Retardé de 15 minutes
14,65
0,03
(0,21%)
Après les heures de négociation: 11:06PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
14,65
Prix Achat
14,45
Prix Vente
15,28
Volume échangé
1 689 885
14,51 Fourchette du Jour 15,38
6,99 Plage de 52 semaines 16,20
Cap du marché
1,738B
Clôture Veille
14,81
Ouverture
14,87
Dernière Transaction
67
@
15
Dernière heure de transaction
Volume financier
US$ 25 258 518
VWAP
14,9469
Volume moyen (3 m)
2 165 645
Actions en circulation
118 638 235
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-12,38
Bénéfice par action (BPA)
-1,18
Chiffre d'affairess
196,54M
Bénéfice net
-140,04M

À propos de Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.arcutis.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Arcutis Biotherapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ARQT. Le dernier cours de clôture d'Arcutis Biotherapeutics était de US$14,81. Au cours de la dernière année, les actions de Arcutis Biotherapeutics ont été négociées dans une fourchette de prix de US$ 6,99 à US$ 16,20.

Arcutis Biotherapeutics compte actuellement 118 638 235 actions en circulation. La capitalisation boursière d'Arcutis Biotherapeutics est de US$1,76 milliard. Arcutis Biotherapeutics a un ratio cours/bénéfice (ratio PE) de -12.38.

ARQT Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
ARQT (-1,28%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
ARQT (-1,28%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
ARQT (-1,28%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
ARQT (-1,28%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 Mars 2025
ARQT (-1,28%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 Mars 2025
ARQT (-1,28%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 Mars 2025
ARQT (-1,28%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 Mars 2025
ARQT (-1,28%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.1350.9300723389614.51516.088313.8181772814.98687131CS
42.0516.269841269812.616.088311.75217022713.61975033CS
120.543.8270729978714.1116.211.13216564513.64219819CS
263.9536.915887850510.716.28.03210057811.93913684CS
523.6533.18181818181116.26.99246057210.54490238CS
156-2.16-12.849494348616.8127.41.7619622599.21349434CS
260-6.79-31.669776119421.4440.881.76124646610.24275051CS

ARQT - Frequently Asked Questions (FAQ)

What is the current Arcutis Biotherapeutics share price?
The current share price of Arcutis Biotherapeutics is US$ 14,65
How many Arcutis Biotherapeutics shares are in issue?
Arcutis Biotherapeutics has 118 638 235 shares in issue
What is the market cap of Arcutis Biotherapeutics?
The market capitalisation of Arcutis Biotherapeutics is USD 1,76B
What is the 1 year trading range for Arcutis Biotherapeutics share price?
Arcutis Biotherapeutics has traded in the range of US$ 6,99 to US$ 16,20 during the past year
What is the PE ratio of Arcutis Biotherapeutics?
The price to earnings ratio of Arcutis Biotherapeutics is -12,38
What is the cash to sales ratio of Arcutis Biotherapeutics?
The cash to sales ratio of Arcutis Biotherapeutics is 8,82
What is the reporting currency for Arcutis Biotherapeutics?
Arcutis Biotherapeutics reports financial results in USD
What is the latest annual turnover for Arcutis Biotherapeutics?
The latest annual turnover of Arcutis Biotherapeutics is USD 196,54M
What is the latest annual profit for Arcutis Biotherapeutics?
The latest annual profit of Arcutis Biotherapeutics is USD -140,04M
What is the registered address of Arcutis Biotherapeutics?
The registered address for Arcutis Biotherapeutics is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Arcutis Biotherapeutics website address?
The website address for Arcutis Biotherapeutics is www.arcutis.com
Which industry sector does Arcutis Biotherapeutics operate in?
Arcutis Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ARQT
Arcutis Biotherapeutics
LSE
FM87
Atlas 2023-1 61
BIT
UR9E4X
UniCredit Bank
NYSE
DUK
Duke Energy
LSE
ADME
Adm Energy
TG
6ME
Metro Mining
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces